The contents of other metabolites in feces were all lower than 0.06% of the administered amount, and it was impossible to perform structural identification because of the extremely low content
We've designed our consultation process at myBMI to be straightforward and focused on what matters most your health and safety
We cannot guarantee the efficacy or safety of the product as individual results may vary
Special Populations While comprehensive data in special populations is limited, consider the following: Geriatric patients: Start at lower doses (200 mcg daily) given potentially altered pharmacokinetics
Vleminckx S, Virgilio N, Asserin J, Prawitt J, Silva CIF
Some studies suggest improvements in structural preservation and functional outcomes, though the mechanisms remain under investigation